National Association of Testing Authorities, Australia
Scope of Accreditation
PathWest Laboratory Medicine WA
Site
Royal Perth Hospital
Accreditation No.
2392
Site No.
2383
Date of Accreditation
30 May 1988
Contact
Ms Milana Ranieri P: +61 (08) 63834567
Availability
Services available to external clients
Supervision
GY (General)
Scope of Accreditation
Royal Perth Hospital
ISO 15189 (2022)
- This facility complies with the relevant National Pathology Accreditation Advisory Council (NPAAC) requirements.
Human Pathology
Medicare expiry date
10 Aug 2027
Last Activity Date
30 Jan 2024
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Analysis of drugs for toxicological (non-legal) purposes and ingested or absorbed toxic chemicals | Plasma | Alcohol |
| Chemical pathology - Detection and/or quantitation of drugs for therapeutic monitoring | Plasma | Amikacin; Ethanol; Lithium; Paracetamol (acetaminophen); Salicylate |
| Carbamazepine; Digoxin; Valproate (valproic acid, epilim); Vancomycin | ||
| Chemical pathology - Detection and/or quantitation of tumour markers | Ascitic fluid | CA19-9 antigen (CA19-9); Carcinoembryonic antigen (CEA) |
| Bile fluid | CA19-9 antigen (CA19-9) | |
| Cerebrospinal fluid (CSF) | α-Fetoprotein (AFP) | |
| Cyst fluid | CA19-9 antigen (CA19-9); Carcinoembryonic antigen (CEA) | |
| Pleural fluid | CA19-9 antigen (CA19-9); Carcinoembryonic antigen (CEA) | |
| Chemical pathology - Determination of hormones and hormone binding proteins (other than thyroid function tests) | Plasma | Parathyroid hormone (PTH) |
| Plasma; Urine | Cortisol | |
| Chemical pathology - Further investigation of cardiac function | Plasma | Troponin |
| B-type natriuretic peptide (BNP); Troponin | ||
| Chemical pathology - Further investigation of lipid profiles for diagnosis of types III and IV hyperlipidaemia | Plasma | HDL - Quantitation |
| Chemical pathology - Further investigation of renal and/or hepatic function | Plasma; Urine | Uric acid |
| Chemical pathology - Haem related pigments and precursors (excluding porphyria) | Cerebrospinal fluid (CSF) | Xanthochromia |
| Chemical pathology - Investigation and determination of hepatic, cardiac, bone, skeletal muscle and other profiles and metabolic studies | Ascitic fluid | Albumin; Amylase; Cholesterol - LDL; Creatinine; Glucose; Lactate dehydrogenase (LDH); Lipase; Potassium; Protein - Total; Sodium; Triglycerides |
| Bile fluid | Bilirubin - Total | |
| Cerebrospinal fluid (CSF) | Lactate | |
| Glucose; Protein - Total | ||
| Glucose; Protein - Total | ||
| Lactate | ||
| Cyst fluid | Amylase; Lipase | |
| Drainage fluid | Amylase; Creatinine; Lipase | |
| Plasma | Alanine aminotransferase; Albumin; Alkaline phosphatase; Ammonia; Amylase; Aspartate aminotransferase; Bicarbonate; Bilirubin - Total; C-reactive protein (CRP); Calcium - Total; Chloride; Cholesterol - LDL; Cholesterol - Total; Creatine kinase; Creatinine; Glucose; Lactate dehydrogenase (LDH); Lipase; Magnesium; Phosphate; Potassium; Protein - Total; Sodium; Triglycerides; Urea; γ-Glutamyltransferase | |
| Plasma; Urine | Osmolality | |
| Pleural fluid | Albumin; Amylase; Cholesterol - LDL; Creatinine; Glucose; Lactate dehydrogenase (LDH); Lipase; Potassium; Protein - Total; Sodium; Triglycerides | |
| Urine | Albumin; Amylase; Calcium - Total; Chloride; Creatinine; Magnesium; Phosphate; Potassium; Protein - Total; Sodium; Urea | |
| pH | ||
| Chemical pathology - Investigation for folate deficiency | Plasma | Folate |
| Chemical pathology - Iron studies | Plasma | Iron; Transferrin |
| Ferritin | ||
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Calcium - Ionised; Carboxyhaemoglobin; Chloride; Glucose; Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Oxygen saturation (sO2); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
| Chemical pathology - Quantitation of vitamins | Plasma | 25-Hydroxyvitamin D; Cobalamin (vitamin B12) |
| Chemical pathology - Tests for thyroid function | Plasma | Thyroid stimulating hormone (TSH); Thyroxine (T4) - Free |
| Haematology - Bone marrow examination | Bone marrow | Examination of aspirated material; Histological examination |
| Haematology - Examination of blood films by special staining | Blood | Malaria |
| Haematology - Full blood examination | Blood | Differential number; Erythrocyte count (red blood cell count, RBCC); Haematocrit (packed cell volume, PCV); Haemoglobin (Hb); Leucocyte count (white blood cell count, WBCC); Platelet count; Red blood cell index or indices; Reticulocytes |
| Morphology | ||
| Haematology - Haemostasis related analysis (including special coagulation testing and platelet function tests) | Blood | Activated partial thromboplastin time (APTT); Anti-Xa activity; D-dimer; Fibrinogen; International normalised ratio (INR); Thrombin time (TT) |
| Viscoelastic haemostatic testing (VHT) | ||
| Haematology - Investigation of haemoglobinopathy (excluding thalassemia) | Blood | Haemoglobin S (HbS) - Presence |
| Haematology - Investigation of haemolysis | Plasma; Urine | Haemoglobin (Hb) |
| Serum | Cold agglutinins | |
| Haematology - Limited blood examination | Blood | Erythrocyte (RBC) sedimentation rate (ESR) |
| Immunohaematology - Blood grouping | Blood | ABO; RhD |
| Immunohaematology - Determination of compatibility of blood donor units | Blood | Direct antiglobulin test (DAT, direct Coombs test); Examination for blood group antibodies; Group checks of patient and donor; Identification of detected antibodies |
| Immunohaematology - Identification and quantitation of blood group antibodies | Blood | Antibody elution |
| Other blood group antibodies; Red blood cell phenotyping; Rh | ||
| Immunohaematology - Issue and release of blood and blood product for transfusion | Blood; Cryoprecipitate; Fresh frozen plasma (FFP); Platelets | Issue and release of blood and blood products for transfusion |
| Immunohaematology - Storage and distribution of blood and blood components | Blood; Blood products | Compliance with transport, storage and distribution requirements of blood, products and components |
| Infertility and pregnancy tests including assisted reproductive technology - Diagnosis or follow up of threatened abortion and/or diagnosis of ectopic pregnancy | Plasma | Human chorionic gonadotropin (hCG) - Quantitative total |
| Microbiology - Bacteriology - Detection and identification of crystalline material | Synovial fluid | Crystal detection and identification |
| Microbiology - Bacteriology - Detection of pathogenic bacteria | Cerebrospinal fluid (CSF); Fluids; Operative specimens; Synovial fluid | Bacteria; Erythrocytes (red blood cells, RBC); Leucocytes (white blood cells, WBC) |
| Cerebrospinal fluid (CSF); Operative specimens; Synovial fluid | Erythrocytes (red blood cells, RBC); Leucocytes (white blood cells, WBC) | |
| Urine | Bacteria; Casts; Crystals; Epithelial cells; Erythrocytes (red blood cells, RBC); Leucocytes (white blood cells, WBC); Urinary sediment | |
| Bilirubin; Blood; Glucose; Ketones; Leucocyte esterase; Nitrite; Proteins; Specific gravity; Urobilinogen; pH | ||
| Microbiology - Bacteriology - Detection of pathogenic bacteria for epidemiological infection control surveillance | Axilla swabs; Nasal swabs; Rectal swabs; Throat swabs; Wounds | Carbapenemase-producing Enterobacterales (CPE); Methicillin resistant Staphylococcus aureus (MRSA); Methicillin susceptible Staphylococcus aureus (MSSA); Vancomycin resistant Enterococci (VRE) |
| Microbiology - Environmental investigations and/or infection control (Clinical non-human testing) | Gastrointestinal endoscopes | Bacterial growth - Sterility; Organism characterisation for patient management |
| Spore strips | Bacterial growth - Sterility | |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (bacteria) | Faeces | Clostridioides difficile toxin |
| Campylobacter spp.; Escherichia coli - Enteroinvasive (EIEC); Escherichia coli - Enterotoxigenic (ETEC); Escherichia coli STEC stx1/stx2; Plesiomonas shigelloides; Salmonella spp.; Shigella spp.; Vibrio spp.; Yersinia enterocolitica | ||
| Nasopharyngeal swabs | Bordetella parapertussis; Bordetella pertussis; Chlamydophila pneumoniae; Mycoplasma pneumoniae | |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (protozoan parasites) | Blood | Malaria |
| Faeces | Cryptosporidium hominis; Cryptosporidium parvum; Cryptosporidium spp.; Entamoeba histolytica; Giardia intestinalis | |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (viruses) | Faeces | Adenovirus F40; Adenovirus F41; Astrovirus; Norovirus G1; Norovirus G2; Rotavirus A; Sapovirus I; Sapovirus II; Sapovirus IV; Sapovirus V |
| Nasal aspirates/washes; Nasal swabs; Nasopharyngeal swabs; Oropharyngeal swabs | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | |
| Nasal swabs; Nasopharyngeal swabs; Throat swabs | Influenza A virus; Influenza B virus; Respiratory syncytial virus (RSV) | |
| Nasopharyngeal swabs | Adenovirus; Coronavirus; Enterovirus; Human metapneumovirus; Influenza A virus; Influenza B virus; Parainfluenza virus type 1/2/3/4; Respiratory syncytial virus (RSV); Rhinovirus; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID); Middle Eastern respiratory syndrome coronavirus (MERS-CoV) | |
| Microbiology - Mycobacteriology - Detection and identification of mycobacteria | Respiratory specimens; Tissues | Mycobacteria detection |
| Microbiology - Mycology - Detection, isolation and/or identification of yeasts and/or fungal elements | Cerebrospinal fluid (CSF); Operative specimens; Synovial fluid; Urine | Yeast detection |
| Microbiology - Parasitology - Detection of ova, cysts and parasites | Blood | Malaria |
| Corneal scrapings | Acanthamoeba spp. | |
| Microbiology - Serology of infection - Microbial antibody and/or antigen detection and/or quantitation | Blood | Infectious mononucleosis |
Diabetes clinic
ISO 15189 (2022)
Human Pathology
Medicare expiry date
10 Aug 2027
Last Activity Date
30 Jan 2024
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Diagnosis and management of diabetes mellitus | Blood | Glycated haemoglobin (HbA1c) |
Emergency Department
ISO 15189 (2022)
Human Pathology
Medicare expiry date
10 Aug 2027
Last Activity Date
30 Jan 2024
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Calcium - Ionised; Carboxyhaemoglobin; Chloride; Creatinine; Glucose; Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
| Infertility and pregnancy tests including assisted reproductive technology - Diagnosis or follow up of threatened abortion and/or diagnosis of ectopic pregnancy | Blood | Human chorionic gonadotropin (hCG) - Quantitative total |
Intensive Care Unit
ISO 15189 (2022)
Human Pathology
Medicare expiry date
10 Aug 2027
Last Activity Date
30 Jan 2024
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Calcium - Ionised; Carboxyhaemoglobin; Chloride; Glucose; Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
Radiology
ISO 15189 (2022)
Human Pathology
Medicare expiry date
10 Aug 2027
Last Activity Date
30 Jan 2024
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Investigation and determination of hepatic, cardiac, bone, skeletal muscle and other profiles and metabolic studies | Blood | Creatinine |
Respiratory Ward
ISO 15189 (2022)
Human Pathology
Medicare expiry date
10 Aug 2027
Last Activity Date
30 Jan 2024
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Calcium - Ionised; Carboxyhaemoglobin; Chloride; Glucose; Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
Theatre
ISO 15189 (2022)
Human Pathology
Medicare expiry date
10 Aug 2027
Last Activity Date
30 Jan 2024
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Diagnosis and management of diabetes mellitus | Blood | Glycated haemoglobin (HbA1c) |
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Calcium - Ionised; Carboxyhaemoglobin; Chloride; Glucose; Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
The only data displayed is that deemed relevant and necessary for the clear description of the activities and services covered by the scope of accreditation.
Grey text appearing in a SoA is additional freetext providing further refinement or information on the data in the preceding line entry.
Accreditation No.
2392
Site No.
2383
Print date
27 Dec 2024
END OF SCOPE